Admission Date:  [**2143-5-21**]              Discharge Date:   [**2143-5-25**]

Date of Birth:  [**2069-9-7**]             Sex:   M

Service: OTOLARYNGOLOGY

Allergies:
Patient recorded as having No Known Allergies to Drugs

Attending:[**Known firstname 7729**]
Chief Complaint:
Right face hematoma

Major Surgical or Invasive Procedure:
Incision and drainage of right face hematoma [**2143-5-21**]


History of Present Illness:
The patient is a 73-year-old male who approximately 5 days prior
to returning to the operating room, underwent a right
superficial parotidectomy and
excision of a malignant melanoma involving the skin. He did well
postoperatively. Due to an artificial heart valve and atrial
fibrillation, his anticoagulation was restarted. Unfortunately,
over the past 24 hours, he has developed an expanding hematoma.
He presents today for evacuation.


Past Medical History:
CAD s/p MI [**54**] years ago, CHF, A-fib, s/p AVR [**2138**] on coumadin,
hypothyroid, AAA

Social History:
He is married with 3 children, ages 38, 36 and 35. He has not
drunk alcohol in 30 years and has not smoked for 25 years. He
used to be in the construction business and more recently worked
for the skating rink at [**University/College 55089**]. He is currently
retired.

Family History:
There is no family history of melanoma. He has a brother, who
died of lung cancer.

Physical Exam:
On day of discharge
Vitals 96.5 96.0 60 102/60 18 93/RA
NAD, A x O x 3
PERRLA, EOMI, Anicteric
CN II-XII grossly intact
WOUND site C/D/I with no hematoma, erythema, or drainage. Suture
line stable.
RRR with appreciable valve click, no r/g
CTA B, no r/r/c
ABD Soft, NT/ND, NABS
EXT Warm and well perfused

Pertinent Results:
[**2143-5-21**] 08:58PM   HCT-28.6*
[**2143-5-21**] 04:40PM   TYPE-ART PO2-262* PCO2-36 PH-7.48* TOTAL
CO2-28 BASE XS-4
[**2143-5-21**] 04:40PM   LACTATE-1.1
[**2143-5-21**] 04:40PM   freeCa-0.99*
[**2143-5-21**] 04:32PM   GLUCOSE-124* UREA N-15 CREAT-1.2 SODIUM-139
POTASSIUM-4.1 CHLORIDE-107 TOTAL CO2-27 ANION GAP-9
[**2143-5-21**] 04:32PM   CALCIUM-7.7* PHOSPHATE-1.9* MAGNESIUM-1.7
[**2143-5-21**] 04:32PM   WBC-10.1# RBC-2.93*# HGB-8.1*# HCT-24.2*#
MCV-83 MCH-27.5 MCHC-33.2# RDW-14.4

Brief Hospital Course:
[**2143-5-21**] Patient presented to ED per HPI above and was taken to
the OR for I/D of right face hematoma.  The patient tolerated
this procedure well, was extubated in the OR, and transferred to
the PACU for recovery.  From the PACU he spent the night in the
SICU for wound site monitoring.  His post-op check was
unremarkable.  He was kept NPO and given IV hydration.
.
[**2143-5-22**] There were no overnight events.  He was transferred to
CC6 floor status for recovery. The patient was OOB to the chair
twice and tolerated it well.  He was given a clear liquid diet
which he tolerated well and advanced to a regular diet. He was
given all PO medications as at home.  His drain output was noted
to be serosanguinous.
.
[**2143-5-23**] There were no overnight events. The patient was OOB to
[**Doctor Last Name **] multiple times.  He was started on a therapeutic heparin
drip.  There was noted to be no increase in incision site
drainage, swelling, or other bleeding.  His foley was removed
and he voided within 6 hours.
.
[**2143-5-24**] There were no overnight advents.  His JP drains were
D/C'd as well as his Ancef.  The wound site was stable, with no
swelling or increased drainage.  He was up ambulating in the
[**Doctor Last Name **] multiple times and "feeling well".
.
[**2143-5-25**] There were no overnight events.  At the time of
discharge he was afebrile, tolerating a regular diet, and
ambulating without assistance.  He had no complaints of pain,
SOB, CP, F/C/N/D/HA.  He was discharged on therapeutic Lovenox
shots [**Hospital1 **] and instructed to follow up with his PCP as soon as
possible for anticoagulation with Coumadin.

Medications on Admission:
1. Levothyroxine 75 mcg Tablet Sig: One (1) Tablet PO DAILY
(Daily).
2. Amiodarone 200 mg Tablet Sig: One (1) Tablet PO DAILY
(Daily).
3. Gabapentin 300 mg Capsule Sig: One (1) Capsule PO QID (4
times a day).
4. Tiotropium Bromide 18 mcg Capsule, w/Inhalation Device Sig:
One (1) Cap Inhalation DAILY (Daily).
5. Pravastatin 20 mg Tablet Sig: Four (4) Tablet PO DAILY
(Daily).
6. Irbesartan 150 mg Tablet Sig: One (1) Tablet PO BID (2 times
a day).
7. Amlodipine 5 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).

8. Furosemide 80 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).



Discharge Medications:
1. Levothyroxine 75 mcg Tablet Sig: One (1) Tablet PO DAILY
(Daily).
2. Amiodarone 200 mg Tablet Sig: One (1) Tablet PO DAILY
(Daily).
3. Gabapentin 300 mg Capsule Sig: One (1) Capsule PO QID (4
times a day).
4. Tiotropium Bromide 18 mcg Capsule, w/Inhalation Device Sig:
One (1) Cap Inhalation DAILY (Daily).
5. Pravastatin 20 mg Tablet Sig: Four (4) Tablet PO DAILY
(Daily).
6. Irbesartan 150 mg Tablet Sig: One (1) Tablet PO BID (2 times
a day).
7. Amlodipine 5 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).

8. Furosemide 80 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).

9. Enoxaparin 60 mg/0.6 mL Syringe Sig: One (1) dose
Subcutaneous Q12H (every 12 hours) for 10 days.
Disp:*20 dose* Refills:*2*
10. Vicodin 5-500 mg Tablet Sig: 1-2 Tablets PO every six (6)
hours as needed for pain.
Disp:*30 Tablet(s)* Refills:*0*
11. Colace 100 mg Capsule Sig: One (1) Capsule PO twice a day.
Disp:*60 Capsule(s)* Refills:*2*
12. Outpatient Lab Work
INR Checks and Coumadin monitoring per PCP.


Discharge Disposition:
Home

Discharge Diagnosis:
s/p hematoma I&D following resection of R face melanoma
AFIB
Mechanical Aortic Valve
Recurrent melanoma to R face

Discharge Condition:
Stable, to home


Discharge Instructions:
Please report to the ER immediately for fever > 101F, increasing
pain from your wound site, persistent nausea/vomiting, shortness
of breath, chest pain, or increasing swelling, redness, or
obvious signs of infection from your wound site.
.
Take your medications exactly as prescribed.  Take your stool
softener as long as you are taking narcotic pain medication.
.
Follow up with your primary care physician PCP as soon as
possible following your discharge for coordinating your Coumadin
therapy.

Followup Instructions:
Please follow up with Dr. [**Last Name (STitle) 1837**] in [**12-26**] weeks following
your discharge. Please call his office to schedule an
appointment.
.
Please follow up with your cardiologist for restarting your
Coumdain therapy.  See him as soon as possible following your
discharge.



